Gcatbio

Founded in 2022, GCATbio Co, Limited is dedicated to advancing life science research through high-throughput DNA synthesis and synthetic biology solutions. Our proprietary DNA synthesizer, mMPS (microchip-based Massive Parallel Synthesis), enables the simultaneous synthesis of thousands to millions of individually barcoded oligonucleotides on microchips, each at the pmol to nmol scale. This breakthrough technology ensures exceptional quality and consistency while significantly improving efficiency, flexibility, and cost-effectiveness. Building on cutting-edge R&D capabilities, GCATbio delivers state-of-the-art solutions in synthetic biology, protein engineering, and biochemistry. We provide oligo synthesis, gene synthesis, capture panels, variant libraries, and custom R&D services, supporting diverse applications in scientific research, high-throughput sequencing, in vitro diagnostics, drug and vaccine development, and animal health. At GCATbio, we combine multidisciplinary innovation with rigorous quality assurance to empower global researchers with reliable, scalable, and next-generation tools for discovery.